4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001209191-23-023402
Chief Executive Officer sold 2,000 shares at $16.13 ($32,252)
- Chief Executive Officer acquired 2,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Harris Todd · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,000 | $2.25 | $4,500 | 1,703,276 | D |
| 2023-04-03 | Sale : show line 2 in the form 10b5-1 | −2,000 | $16.13 | $32,252 | 1,701,276 | D |
| Open-market sales · 2,000 sh · avg $16.13 · $32,252 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-03 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −2,000 | 397,537 | D |
Loading xslF345X04/doc4.xml…